China Legal Blog
Aggregated China Law Information
2026-09-30
Merck’s PD-1 Inhibitor Pembrolizumab Subcutaneous Injection Approved in China
Aggregated Source: China Money Network
Merck, a pharmaceutical company based in Kenilworth, New Jersey, announced that its PD-1 inhibitor pembrolizumab subcutaneous injection has been approved...
Original URL: Click here to visit original article
Copyright China Money Network